Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mark White, Interim CEO of FOXO: “While we regret the delay, we have been in contact with the NYSE and look forward to presenting our compliance plan in light of recent developments, including our recently announced planned acquisitions, which we believe would generate meaningful cashflow for the combined companies."
I'll check, but I already had an EM in my portfolio when switched to Schwab. I discussed it with them back then. Placed a GTC sell order it and was assured I could trade the position if it for some reason begins trading actively.
FOXO support still looks pretty solid.
Schwab. Have to call in the order on an EM.
They'll still be here after SEC registration application for NYSE listing is approved. They never cared about the earnings reports before.
Depends on the broker. Broker restrictions vary and some appear to be calendar triggered automatically. As far as EM goes, I can buy EM anytime I choose.
As I've said all along, proxy material gets filed next. Current OTC filings not the objective.
Through TD Ameritrade or through Schwab?
Must be your brokerage.
It's pink.
OTC Markets Group has nothing to do with SEC compliance. Nada. SEC is the decider.
RNVA included preliminary 10-K earnings in the 8-K on the FOXO deal so investors would not remain in the dark. RNVA has a PE of 0.83 with an SEC registration application for an NYSE listing pending. That's the deal.
No mystery here. It's all in the filings so far. RNVA is working through the SEC on proxy materials and financials that will meet SEC standards for the FOXO supplemental (NYSE) listing application also to be filed. It's a BFD. Patience while they get this right.
Still pink.
LOL. RNVA reports to the SEC. OTC Markets Group doesn't have anything to do with it. OTC Markets Group handles OTCs that are not SEC compliant. "Current" on OTC Markets Group means current but noncompliant.
Still pink on my screen. Next filing will be the proxy materials on the FOXO deal including financials. This whole thing is about the application(s) for material change(s) in the SEC registration.
Pennies on more earnings growth plus rational speculation after announcement that the CAH model will be replicated at Jamestown.
$5.2 million earnings/43 billion shares=.00012 EPS. .0001 PPS/.00012 EPS=0.83 PE. A PE of 20 equals a price of .0024. Deserve it. Earned it.
Top of OTC volume list. Not much OTC volume today except for RNVA. Getting interesting for sure.
Let us know when the ticker does a triple summersault
There was a 2 billion share ask at .0001 not so long ago. It will churn through the .0002 flips.
I'm beginning to think this will be a full merger and we will eventually be issued FOXO shares for RNVA shares. Don't hold me to that, but for all practical purposes RNVA is FOXO and FOXO is RNVA.
I think the RNVA corporate equity buybacks will be completed in the process and all will be restructured as one company under the NYSE listing, probably with a change of ticker symbol. Again, I don't know, just what I think.
It's a process.
Man, you don't even have your eye on the ball. RNVA will not be dropped to CE with a SEC registration application pending for a NYSE listing. The proxy materials will break down the equity interests in FOXO under a newly constituted, RNVA controlled board. Rennova Health, Inc. (RNVA) shareholders will own Rennova Community Health, Inc. and Myrtle Recovery Centers, Inc., plus FOXO Technologies, Inc, together generating $5.2 million in 2023 earnings on about $19 million in revenues. The PE is 0.83. A current PE of 20 will equal stock price of .0024.
Can you translate dingbatt script?
The accounting and legal work in this situation is a lot like an IPO. The financials are just a piece of it. No doubt RNVA has been consulting with the SEC for months on the FOXO share exchange. All good.
No, FOXO got out of that business.
Still pink. I'm thinking it will stay pink until new SEC registration application(s) is(are) approved. Audited financials involved, but we don't even know what ticker symbol and exchange they will be filed under yet.
Pink on my screen.
Thanks. Good for the rest of us. Clearing out the resistance.
SEC registration application(s) in progress. RNVA has surely been in consultation with the SEC about it for months, before and after the share exchange agreements were reached. EM not just overblown but irrelevant. RNVA works through a SEC desk officer to which it is assigned. I don't know the procedural details, but I'm sure we're good.
FOXO had been shopping an MA for quite some time. Giving up their patents for a piece of a much larger profitable company capable of commercializing them, and putting up $2.5 million for the privilege.
Plus, FOX threw in $2.5 million.
Don't hold me to this exactly, but I'm estimating that RNVA (Rennova Health, Inc.) will own 85% or more of the equity in FOXO (Rennova Community Health, Inc., Myrtle Recovery Centers, Inc., and FOXO Technologies, Inc.).
He can't say much privately that has not yet been made public. I'll wait for the proxy material, but all good from what I've seen so far.
Exactly. The RNVA CEO and BoD will control FOXO. RNVA shareholders will own the equity they control. The value of their equity depends on the value of our equity.
We don't yet know how or even if FOXO Technologies will be listed either, or if maybe Myrtle Recovery will be listed. Discussions of late filings under the RNVA "ticker" miss the point.
The share exchange agreements will make Rennova Healthcare, Inc. the parent company of wholly-owned subsidiary FOXO Technologies along with Myrtle Recovery which is already a wholly-owned subsidiary. That much is not a theory. We should find out more about how Rennova Healthcare, Inc. will be listed when the proxy materials come out, but it really shouldn't matter. The fundamentals are the same.